Sex differences in the effect of diabetes duration on coronary heart disease mortality

Archives of Internal Medicine

Volumn 165, Issue 4, 2005, Pages 430-435

  Natarajan, Sundar ^a,f   Liao, Youlian ^b   Sinha, Debajyoti ^c   Cao, Guichan ^d   McGee, Daniel L ^e   Lipsitz, Stuart R ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e FLORIDA STATE UNIVERSITY   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; CHOLESTEROL; COMORBIDITY; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 14044255865     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.4.430     Document Type: Article

References (29)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
2. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291-1297.
3. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? the Rancho Bernardo Study. JAMA. 1991;265:627-631.
4. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med. 2003;163:1735-1740.
5. Miller HW. Plan and operation of the Health and Nutrition Examination Survey, United States - 1971-1973: part A, development, plan and operation. Vital Health Stat 1. 1973;No. 10a:1-46.
6. Cox CS, Mussolino ME, Rothwell ST, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1992. Vital Health Stat 1. 1997;No. 35:1-231.
7. Cox CS, Rothwell ST, Madans JH, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1987. Vital Health Stat 1. 1992;No. 27:1-190.
8. Finucane FF, Freid VM, Madans JH, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1986. Vital Health Stat 1. 1990;No. 25:1-154.
9. Cohen BB, Barbano HE, Cox CS, et al. Plan and operation of the NHANES I Epidemiologic Followup Study: 1982-84, Vital Health Stat 1. 1987;No. 22:1-142.
10. Madans JH, Reuben CA, Rothwell ST, Eberhardt MS. Differences in morbidity measures and risk factor identification using multiple data sources: the case of coronary heart disease. Stat Med. 1995;14:643-653.
11. Machlin SR, Kleinman JC, Madans JH. Validity of mortality analysis based on retrospective smoking information. Stat Med. 1989;8:997-1009.
12. Cox DR. Regression models with life tables. J R Stat Soc Ser B Methodol. 1972; 74:187-220.
13. SAS/STAT User's Guide. Cary, NC: SAS Institute Inc; 1999.
14. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Release 8.0. Research Triangle Park, NC: Research Triangle Institute; 2001.
15. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: the Strong Heart Study. Diabetes Care. 1998;21:1258-1265.
16. Steinberg HO, Paradisi G, Cronin J, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000; 101:2040-2046.
17. Evans RW, Orchard TJ. Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction? Metabolism. 1994;43:1196-1200.
18. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension. 1997;29:691-699.
19. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43:960-967.
20. Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes. 1993;42:8-11.
21. Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med. 1991;325:836-842.
22. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161:1717-1723.
23. Orchard TJ. From diagnosis and classification to complications and therapy, DCCT, II: Diabetes Control and Complications Trial. Diabetes Care. 1994;17:326-338.
24. IOM Committee on Understanding the Biology of Sex and Gender Differences. Sex affects health. In: Wizemann TM, Pardue M, eds. Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC: National Academy Press; 2001:93-136.
25. Bowlin SJ, Morrill BD, Nafziger AN, Jenkins PL, Lewis C, Pearson TA. Validity of cardiovascular disease risk factors assessed by telephone survey: the Behavioral Risk Factor Survey. J Clin Epidemiol. 1993;46:561-571.
26. Tretli S, Lund-Larsen PG, Foss OP. Reliability of questionnaire information on cardiovascular disease and diabetes; cardiovascular disease study in Finnmark county. J Epidemiol Community Health. 1982;36:269-273.
27. Rosamond WD, Sprafka JM, McGovern PG, Nelson M, Luepker RV. Validation of self-reported history of acute myocardial infarction: experience of the Minnesota Heart Survey Registry. Epidemiology. 1995;6:67-69.
28. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
29. Grover SA, Coupai L, Zowall H, Alexander CM, Weiss TW, Gomes DR. How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease? Diabetes Care. 2001;24:45-50.